Gene-based blood test for melanoma spread evaluates treatment progress
Scienmag
FEBRUARY 12, 2021
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds. Led by NYU Grossman School of Medicine and Perlmutter Cancer Center researchers, […].
Let's personalize your content